Rotavirus Vaccine Completed Phase 3 Trials for Neisseria Meningitidis / Haemophilus Influenzae Type B Prevention

CompletedPrevention3 IdentifierTitleDrugs
NCT01978093Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age
NCT01000974Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants